Main Session
Sep
29
PQA 05 - Breast Cancer, Health Services Research, International/Global Oncology
2986 - The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
Presenter(s)
Rachel Rabinovitch, MD, FASTRO - University of Colorado Cancer Center, Aurora, CO